Special Issues
Table of Content

Advances in Pathology, Early Diagnosis and Therapeutic Strategies for Breast Cancer

Submission Deadline: 31 December 2025 View: 797 Submit to Special Issue

Guest Editors

Dr. Virginia Valentini

Email: virginia.valentini@uniroma1.it

Affiliation: Department of Molecular Medicine, Sapienza University of Rome, Rome, 00161, Italy

Homepage:

Research Interests: Breast Cancer, Male Breast Cancer, genetic susceptibility, molecular characterization of cancer, potential prognostic and/or predictive biomarkers, innovative and personalized preventive and therapeutic strategies.


Dr. Agostino Bucalo

Email: agostino.bucalo@uniroma1.it

Affiliation: Department of Molecular Medicine, Sapienza University of Rome, Rome, 00161, Italy

Homepage:

Research Interests: Male breast cancer, NGS of gene panels, genetic predisposition to breast cancer


Summary

This special issue explores the impact of the characterization and integration of molecular biomarkers in the classification and treatment of breast cancer (BC). Despite advances in therapeutics and improved overall survival rates, the mortality rate from BC remains a significant global challenge. Research into the genetic and epigenetic landscape of BC is expanding thanks to new technologies, and molecular biomarkers are increasingly influencing its diagnosis and treatment.


New therapeutic approaches have emerged through the validation of specific biomarkers, improving treatment outcomes in female BC patients. On the other hand, clinical management and therapeutic options for male BC patients are still largely based on female BC research, leading to poorer outcomes for male patients due to gender-specific differences.


Another central theme is the use of Next Generation Sequencing to identify novel susceptibility genes and therapeutic biomarkers, which are crucial for personalized therapy. A deeper understanding of molecular genetics enables early diagnosis, preventive strategies, and personalized treatments, even for male patients.
This special issue invites researchers to submit original research articles and reviews exploring these topics, including advanced genetic studies, innovative methods, and personalized therapeutic approaches for both female and male BC patients.


Keywords

Female and male breast cancer; Hereditary cancer; Breast cancer risk; Cancer genetics; Molecular oncology; Tumor profiling; Next Generation Sequencing; Prognostic and/or predictive biomarkers; Circulating miRNA; Personalized treatment

Published Papers


  • Open Access

    REVIEW

    Targeting Sphingolipids in Breast Cancer: From Tumor Biology to Therapeutic Strategies

    Min Hee Kim, Boyoon Huh, Joo-Won Park, Woo-Jae Park
    Oncology Research, DOI:10.32604/or.2025.071523
    (This article belongs to the Special Issue: Advances in Pathology, Early Diagnosis and Therapeutic Strategies for Breast Cancer)
    Abstract Breast cancer is one of the most prevalent malignancies among women and comprises a heterogeneous spectrum of molecular subtypes with distinct biological behaviors. Among various regulatory molecules, sphingolipids play pivotal roles in dynamically modulating fundamental cellular processes such as proliferation, apoptosis, and metastasis through metabolic interconversions, including phosphorylation, glycosylation, and the generation of sphingosine-1-phosphate. This review aims to elucidate the mechanisms through which sphingolipid metabolism orchestrates cancer cell fate and drives breast cancer progression. Particular emphasis is placed on the balance between proapoptotic ceramides and pro-survival metabolites, such as sphingosine-1-phosphate, which collectively influence tumor growth More >

  • Open Access

    REVIEW

    Male Breast Cancer: Epidemiology, Diagnosis, Molecular Mechanisms, Therapeutics, and Future Prospective

    Ashok Kumar Sah, Ranjay Kumar Choudhary, Velilyaeva Alie Sabrievna, Karomatov Inomdzhon Dzhuraevich, Anass M. Abbas, Manar G. Shalabi, Nadeem Ahmad Siddique, Raji Rubayyi Alshammari, Navjyot Trivedi, Rabab H. Elshaikh
    Oncology Research, DOI:10.32604/or.2025.068238
    (This article belongs to the Special Issue: Advances in Pathology, Early Diagnosis and Therapeutic Strategies for Breast Cancer)
    Abstract Male breast cancer (MBC) is rare, representing 0.5%–1% of all breast cancers, but its incidence is increasing due to improved diagnostics and awareness. MBC typically presents in older men, is human epidermal growth factor receptor 2 (HER2)-negative and estrogen receptor (ER)-positive, and lacks routine screening, leading to delayed diagnosis and advanced disease. Major risk factors include hormonal imbalance, radiation exposure, obesity, alcohol use, and Breast Cancer Gene 1 and 2 (BRCA1/2) mutations. Clinically, it may resemble gynecomastia but usually appears as a unilateral, painless mass or nipple discharge. Advances in imaging and liquid biopsy have More >

Share Link